171 related articles for article (PubMed ID: 35011808)
1. Comparison of Acquired Activated Protein C Resistance, Using the CAT and ST-Genesia
Efthymiou M; Lane PJ; Isenberg D; Cohen H; Mackie IJ
J Clin Med; 2021 Dec; 11(1):. PubMed ID: 35011808
[TBL] [Abstract][Full Text] [Related]
2. Anti-protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome.
Arachchillage DR; Efthymiou M; Mackie IJ; Lawrie AS; Machin SJ; Cohen H
J Thromb Haemost; 2014 Nov; 12(11):1801-9. PubMed ID: 25196808
[TBL] [Abstract][Full Text] [Related]
3. Anti-protein C antibodies and acquired protein C resistance in SLE: novel markers for thromboembolic events and disease activity?
Ramirez GA; Mackie I; Nallamilli S; Pires T; Moll R; Pericleous C; Isenberg DA; Cohen H; Efthymiou M
Rheumatology (Oxford); 2021 Mar; 60(3):1376-1386. PubMed ID: 32964932
[TBL] [Abstract][Full Text] [Related]
4. Hypercoagulability (thrombin generation) in patients with cirrhosis is detected with ST-Genesia.
Talon L; Sinegre T; Lecompte T; Pereira B; Massoulié S; Abergel A; Lebreton A
J Thromb Haemost; 2020 Sep; 18(9):2177-2190. PubMed ID: 32558351
[TBL] [Abstract][Full Text] [Related]
5. Application of the thrombin generation assay in patients with antiphospholipid syndrome: A systematic review of the literature.
Gehlen R; Vandevelde A; de Laat B; Devreese KMJ
Front Cardiovasc Med; 2023; 10():1075121. PubMed ID: 37057100
[TBL] [Abstract][Full Text] [Related]
6. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study.
Zuily S; Regnault V; Guillemin F; Kaminsky P; Rat AC; Lecompte T; Wahl D
Thromb Res; 2013 Jul; 132(1):e1-7. PubMed ID: 23676348
[TBL] [Abstract][Full Text] [Related]
7. Study of thrombin generation with St Genesia to evaluate xaban pharmacodynamics: Analytical performances over 18 months.
Foulon-Pinto G; Jourdi G; Perrin J; Abdoul J; Paris G; Gouin-Thibault I; Curis E; Lecompte T; Siguret V
Int J Lab Hematol; 2021 Aug; 43(4):821-830. PubMed ID: 33369212
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Two Thrombin Generation Methods, CAT and ST-Genesia, in Liver Transplant Patients.
Roullet S; Labrouche S; Freyburger G
Thromb Haemost; 2019 Jun; 119(6):899-905. PubMed ID: 31005063
[TBL] [Abstract][Full Text] [Related]
9. Hypercoagulability Evaluation in Antiphospholipid Syndrome without Anticoagulation Treatment with Thrombin Generation Assay: A Preliminary Study.
Billoir P; Miranda S; Levesque H; Benhamou Y; Le Cam Duchez V
J Clin Med; 2021 Jun; 10(12):. PubMed ID: 34205545
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated Thrombogram.
Helin TA; Lemponen M; Lassila R; Joutsi-Korhonen L
Res Pract Thromb Haemost; 2021 Mar; 5(3):439-446. PubMed ID: 33870029
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of acquired activated protein C resistance in patients with systemic lupus erythematosus.
Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Espinosa G; Cervera R; Carmona F; Balsch J; Ingelmo M; Ordinas A
Lupus; 2002; 11(11):730-5. PubMed ID: 12475003
[TBL] [Abstract][Full Text] [Related]
12. Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus.
Male C; Mitchell L; Julian J; Vegh P; Joshua P; Adams M; David M; Andrew ME
Blood; 2001 Feb; 97(4):844-9. PubMed ID: 11159506
[TBL] [Abstract][Full Text] [Related]
13. Thrombin generation measured on ST Genesia, a new platform in the coagulation routine lab: Assessment of analytical and between-subject variation.
Kristensen SR; Nybo J; Pedersen S
Res Pract Thromb Haemost; 2022 Jan; 6(1):e12654. PubMed ID: 35128301
[TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the analyzer ST Genesia.
Modi Omasombo N; Demulder A; Rozen L
Ann Biol Clin (Paris); 2022 Mar; 80(2):148-155. PubMed ID: 35766075
[TBL] [Abstract][Full Text] [Related]
16. Calibrated automated thrombogram II: removing barriers for thrombin generation measurements.
Giesen PLA; Gulpen AJW; van Oerle R; Ten Cate H; Nagy M; Spronk HMH
Thromb J; 2021 Aug; 19(1):60. PubMed ID: 34454531
[TBL] [Abstract][Full Text] [Related]
17. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
18. Thrombin generation in antiphospholipid syndrome.
Zuily S; Ait Aissa K; Membre A; Regnault V; Lecompte T; Wahl D
Lupus; 2012 Jun; 21(7):758-60. PubMed ID: 22635224
[TBL] [Abstract][Full Text] [Related]
19. Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL).
Savelli SL; Roubey RAS; Kitzmiller KJ; Zhou D; Nagaraja HN; Mulvihill E; Barbar-Smiley F; Ardoin SP; Wu YL; Yu CY
Front Immunol; 2019; 10():885. PubMed ID: 31134052
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality.
Riancho-Zarrabeitia L; Martínez-Taboada V; Rúa-Figueroa I; Alonso F; Galindo-Izquierdo M; Ovalles J; Olivé-Marqués A; Fernández-Nebro A; Calvo-Alén J; Menor-Almagro R; Tomero-Muriel E; Uriarte-Isacelaya E; Botenau A; Andres M; Freire-González M; Santos Soler G; Ruiz-Lucea E; Ibáñez-Barceló M; Castellví I; Galisteo C; Quevedo Vila V; Raya E; Narváez-García J; Expósito L; Hernández-Beriaín JA; Horcada L; Aurrecoechea E; Pego-Reigosa JM
Lupus; 2020 Oct; 29(12):1556-1565. PubMed ID: 32807021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
